Rui Wei

548 total citations
21 papers, 398 citations indexed

About

Rui Wei is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Rui Wei has authored 21 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Biomedical Engineering and 6 papers in Oncology. Recurrent topics in Rui Wei's work include Nanoplatforms for cancer theranostics (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Rui Wei is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer, Stress, Anesthesia, and Immune Response (3 papers). Rui Wei collaborates with scholars based in China, United States and Sweden. Rui Wei's co-authors include Guiying Jiang, Fei Li, Ding Ma, Ying Zhou, Jili Zhang, Xiaohong Wang, Danfeng Luo, Sylvia H. Larsson, Yan Huang and Michael Finell and has published in prestigious journals such as Biomass and Bioenergy, European Journal of Medicinal Chemistry and Bioconjugate Chemistry.

In The Last Decade

Rui Wei

18 papers receiving 396 citations

Peers

Rui Wei
Caymen M. Novak United States
Rui Wei
Citations per year, relative to Rui Wei Rui Wei (= 1×) peers Caymen M. Novak

Countries citing papers authored by Rui Wei

Since Specialization
Citations

This map shows the geographic impact of Rui Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Wei more than expected).

Fields of papers citing papers by Rui Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Wei. The network helps show where Rui Wei may publish in the future.

Co-authorship network of co-authors of Rui Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Wei. A scholar is included among the top collaborators of Rui Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Wei. Rui Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Fang, Hua Chen, Chenlu Zhu, et al.. (2025). Neoepitope BTLAP267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma. Cancer Biology and Medicine. 22(4). 1–21.
4.
Yin, D., Fei Li, Xia Li, et al.. (2025). GLP-1 receptor agonists show no detrimental effect on sperm quality in mouse models and cell lines. Endocrine. 89(2). 614–626. 1 indexed citations
5.
Zhou, Ying, Rui Wei, Ling Wang, et al.. (2024). Tumor targeting peptide TMTP1 modified Antigen capture Nano-vaccine combined with chemotherapy and PD-L1 blockade effectively inhibits growth of ovarian cancer. Journal of Nanobiotechnology. 22(1). 10 indexed citations
6.
Wang, Xueqian, Guiying Jiang, Danya Zhang, et al.. (2023). A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy. Journal of Nanobiotechnology. 21(1). 130–130. 19 indexed citations
7.
Sun, Yue, et al.. (2023). Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting. Current Issues in Molecular Biology. 45(7). 6116–6139. 4 indexed citations
8.
Zhou, Ying, Canhui Cao, Shitong Lin, et al.. (2022). The exon 12‐containing LHX6 isoforms promote cervical cancer cell proliferation by regulating the MAPK signaling pathway. Cancer Medicine. 11(19). 3657–3673. 6 indexed citations
9.
Wang, Ling, Danya Zhang, Fei Li, et al.. (2021). A novel ICG-labeled cyclic TMTP1 peptide dimer for sensitive tumor imaging and enhanced photothermal therapy in vivo. European Journal of Medicinal Chemistry. 227. 113935–113935. 21 indexed citations
10.
Jiang, Guiying, Xueqian Wang, Ying Zhou, et al.. (2021). TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy. International Journal of Nanomedicine. Volume 16. 4087–4104. 23 indexed citations
11.
Zou, Chenming, Guiying Jiang, Xueqin Gao, et al.. (2019). Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma. Nanomedicine Nanotechnology Biology and Medicine. 22. 102092–102092. 18 indexed citations
12.
Wei, Rui, Guiying Jiang, Songwei Tan, et al.. (2019). TMTP1-modified Indocyanine Green-loaded Polymeric Micelles for Targeted Imaging of Cervical Cancer and Metastasis Sentinel Lymph Node in vivo. Theranostics. 9(24). 7325–7344. 42 indexed citations
13.
Xiao, Wei, Rui Wei, Guiying Jiang, et al.. (2019). Mechanical Cues Modulate Cellular Uptake of Nanoparticles in Cancer Via Clathrin-Mediated and Caveolae-Mediated Endocytosis Pathways. Nanomedicine. 14(5). 613–626. 21 indexed citations
14.
Zhou, Ying, Wei Wang, Rui Wei, et al.. (2019). Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2. International Journal of Oncology. 55(1). 131–141. 22 indexed citations
15.
Jiang, Guiying, Wei Wang, Rui Wei, et al.. (2018). A Novel Near-Infrared Fluorescent Probe TMTP1-PEG4-ICG for in Vivo Tumor Imaging. Bioconjugate Chemistry. 29(12). 4119–4126. 21 indexed citations
16.
Wei, Rui, Fei Li, Teng Cheng, et al.. (2017). Human CAFs promote lymphangiogenesis in ovarian cancer via the Hh-VEGF-C signaling axis. Oncotarget. 8(40). 67315–67328. 36 indexed citations
17.
Huang, Yan, Michael Finell, Sylvia H. Larsson, et al.. (2017). Biofuel pellets made at low moisture content – Influence of water in the binding mechanism of densified biomass. Biomass and Bioenergy. 98. 8–14. 83 indexed citations
18.
Cheng, Teng, Rui Wei, Guiying Jiang, et al.. (2017). XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis. Tumor Biology. 39(7). 3726133312–3726133312. 15 indexed citations
19.
Li, Fei, Teng Cheng, Rui Wei, et al.. (2015). SPECT imaging of interleukin-6 receptor in ovarian tumor xenografts with a novel radiotracer of 99mTc-HYNIC-Aca-LSLITRL. Amino Acids. 48(1). 91–101. 8 indexed citations
20.
Li, Fei, Teng Cheng, Qingjian Dong, et al.. (2014). Evaluation of 99mTc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. Nuclear Medicine and Biology. 42(3). 256–262. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026